[{"Assets_0_Q3_USD":5527850000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":688603000.0,"NetIncomeLoss_1_Q3_USD":102276000.0,"NetIncomeLoss_3_Q3_USD":449375000.0,"StockholdersEquity_0_Q3_USD":3054405000.0,"EarningsPerShareBasic_1_Q3_USD":1.8,"EarningsPerShareBasic_3_Q3_USD":7.9,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":56674000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":56860000.0,"Ticker":"JAZZ","CIK":"1232524","name":"JAZZ PHARMACEUTICALS PLC","OfficialName":"Jazz Pharmaceuticals plc Common Stock (Ireland)","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"10281986580.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191105"}]